Fibrobiologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.25

+0.02 (+10.83%)

As of Feb 8, 2:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +7,941.3% upside

Low Target $14.74

Average Target $20.24

High Target $23.30

Current Price $0.25

Current
$0.25

Target
$20.24

$14.74 $20.24 avg $23.30

Scenario Analysis

Bear Case

$14.74

5,756.2%

Low target

Base Case

$20.24

+7,941.3%

Avg target

Bull Case

$23.30

+9,157.1%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$21.67

-98.8% from high

52-Week Low

$8.32

+-97.0% from low

Target vs 52W High

$20.24

-6.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%